ALK-Abelló (Denmark)

ALK-Abelló (Denmark)

ALK-Abelló A/S, also commonly known as ALK, is a Denmark-based pharmaceutical company which specializes in the development and manufacturing of allergy immunotherapy products for the prevention and treatment of allergy. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for ALK-Abelló (Denmark), Denmark, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

49%


Total
Publications

745


Total Open
Publications

368


Total
Citations

25K


Open Access
Percentage

49%


Total
Publications

745


Total Open
Publications

368


Total
Citations

25K

Wikipedia

Website

download

Breakdown

30% 15% 4% 51%

Publisher Open

30%

Both

15%

Other Platform Open

4%

Closed

51%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

05101520253035404550Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

21%OA Journal

OA Journal 21%

70

Hybrid 26%

87

No Guarantees 53%

177

Other Platform Open

Domain 64%

92

Institution 34%

48

Other Internet 16%

23

Public 10%

15

Preprint 4%

6

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
94
Europe PMC
Domain
43
Semantic Scholar
Public
13
Technical University of Denmark, DTU - Technical University of Denmark, DTU Orbit
Institution
10
University College London - UCL Discovery
Institution
8
University of Southern Denmark - University of Southern Denmark Research Portal
Institution
7
DOI
Other Internet
7
Elsevier - Scopus
Other Internet
6
Unknown Repository
Other Internet
5
King's College London - Research Portal
Institution
5
1 / 7

Data updated 7 October 2024

Share

Share

Share